Recent Press Releases http://www.hyperiontx.com Hyperion, Inc. Hyperion Therapeutics Names Bruce F. Scharschmidt CMO http://www.hyperiontx.com/press/release/pr_1209163723 Hyperion Therapeutics, Inc. today announced that it has named Bruce F. Scharschmidt, MD as Chief Medical... Thu, 01 Jan 1970 00:33:28 +0000 Hyperion Therapeutics Elects Lota Zoth to Board of Directors http://www.hyperiontx.com/press/release/pr_1207180840 Hyperion Therapeutics, Inc., a privately held biopharmaceutical company, today announced that Lota S.... Thu, 01 Jan 1970 00:33:28 +0000 Hyperion Therapeutics Announces Enrollment of First Patient in Phase 2 Clinical Trial in Patients with Hepatic Encephalopathy http://www.hyperiontx.com/press/release/pr_1203703379 Hyperion Therapeutics, Inc. today announced that the first patient has been enrolled in a Phase 2 clinical... Thu, 01 Jan 1970 00:33:28 +0000 Hyperion Therapeutics to Present at BIO CEO Investor Conference http://www.hyperiontx.com/press/release/pr_1202349171 Hyperion Therapeutics, Inc. today announced that the company is scheduled to present at the BIO CEO and... Thu, 01 Jan 1970 00:33:28 +0000 Hyperion Therapeutics, Inc. Names Mark Spring Senior Vice President and Chief Financial Officer http://www.hyperiontx.com/press/release/pr_1200678305 Hyperion Therapeutics, Inc. today announced the appointment of Mark Spring as Senior Vice President and... Thu, 01 Jan 1970 00:33:28 +0000 William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman http://www.hyperiontx.com/press/release/pr_1199493564 Hyperion Therapeutics, Inc., a privately-held biopharmaceutical company focused on the development... Thu, 01 Jan 1970 00:33:28 +0000 Hyperion Therapeutics Announces Enrollment of First Patient in Phase 1/2 Clinical Trial of GT4P in Patients with Urea Cycle Disorders http://www.hyperiontx.com/press/release/pr_1193092819 Hyperion Therapeutics, Inc. today announced that the first patient has been enrolled in a Phase 1/2 clinical... Thu, 01 Jan 1970 00:33:27 +0000 Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event http://www.hyperiontx.com/press/release/pr_1191524267 Hyperion Therapeutics, Inc., a privately-held biopharmaceutical company focused on the development and... Thu, 01 Jan 1970 00:33:27 +0000 Hyperion Therapeutics Secures $40 Million in Series B Round http://www.hyperiontx.com/press/release/pr_1188930967 Hyperion Therapeutics, a biopharmaceutical company focused on the development and commercialization of... Thu, 01 Jan 1970 00:33:27 +0000 Medicis and Hyperion Therapeutics Announce Strategic Collaboration http://www.hyperiontx.com/press/release/pr_1188254706 Medicis (NYSE:MRX) and Hyperion Therapeutics, Inc. (“Hyperion”) today announced a strategic... Thu, 01 Jan 1970 00:33:27 +0000